Recce Pharmaceuticals Ltd (ASX:RCE)
Australia · Delayed Price · Currency is AUD 0.3850
0.00 (0.00%)
Aug 11, 2026, 4:10 PM AEST
Recce Pharmaceuticals Market Cap
Recce Pharmaceuticals has a market cap or net worth of 115.3 million as of August 11, 2026. Its market cap has increased by 6.32% in one year.
Market Cap
115.30M
Enterprise Value
115.74M
Revenue
974.56K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.39
ChartMarket Cap Chart
Since January 15, 2016, Recce Pharmaceuticals's market cap has increased from 20.55M to 115.30M, an increase of 461.12%. That is a compound annual growth rate of 17.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 115.30M | -38.66% |
| Dec 31, 2025 | 187.97M | 67.15% |
| Dec 31, 2024 | 112.46M | 3.19% |
| Dec 29, 2023 | 108.98M | -7.28% |
| Dec 30, 2022 | 117.53M | -34.34% |
| Dec 31, 2021 | 179.00M | -2.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dimerix | 165.11M |
| Actinogen Medical | 153.63M |
| Island Pharmaceuticals | 133.16M |
| Alterity Therapeutics | 112.02M |
| Paradigm Biopharmaceuticals | 103.95M |
| Prescient Therapeutics | 92.53M |
| LTR Pharma | 86.34M |
| Avecho Biotechnology | 85.00M |